Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
hsa-mir-631: Hsa-mir-631 is a microRNA that has been studied in various contexts [PMC7139792][PMC5945511][PMC9792611][PMC5519761][PMC6753562]. During the development of bortezomib resistance in cells, the levels of hsa-mir-631 are decreased, leading to an increase in UBE2C gene expression [PMC7139792]. In primary resistant/refractory tumors, hsa-mir-631 is down-regulated [PMC5945511]. In prostate cancer cells, hsa-mir-631 inhibits migration and invasion by targeting ZAP70 [PMC5945511]. In PBMAH subtype 2, the expression of hsa-mir-631 is significantly lower compared to adenoma [PMC9792611]. However, during validation by qRT-PCR, the expression of hsa-mir-631 was not significantly altered between adenoma and PBMAH [PMC9792611]. Hsa-mir-631 has also been used as an internal control in plasma exosomes analysis [PMC5519761]. In OSAHS patients compared to controls, hsa-mir-631 was not significantly differentially expressed [PMC6753562].
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset
